HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Healthcare
Bear Case

Investors should be bearish about investing in HCA Healthcare, Inc. for these reasons:

• Several major institutional investors have reduced their stakes in the company recently, including Argent Capital Management LLC which sold 65,181 shares in the third quarter and CX Institutional which cut its holdings by 69.0%, suggesting that some large players are taking profits or losing confidence in the stock's near-term trajectory.
• The stock has experienced significant volatility and a decline from its 52-week high of $556.52 to the current price of $434.54, reflecting a drop of over 20% from its peak, which may indicate broader market concerns about the healthcare sector or specific company risks that have not yet been fully resolved.
• HCA Healthcare, Inc. is facing legal and regulatory scrutiny, as evidenced by the Pomerantz Law Firm investigating claims on behalf of investors and a possible settlement in an antitrust lawsuit against Mission Hospital, which could lead to additional costs, reputational damage, or operational restrictions for the company.
• Insider selling activity has been notable in recent months, with executives such as Michael R. McAlevey, Jennifer Berres, and Christopher F. Wyatt selling thousands of shares in early 2026, which may signal that company insiders are less confident in the stock's future performance or are simply diversifying their personal portfolios.
• The company's negative return on equity of 244.79% reported in the latest quarter, despite positive net margins, raises questions about the efficiency of its capital structure and debt levels, which could limit its ability to invest in growth initiatives or withstand economic downturns without significant financial strain.